Sex-specific hippocampal metabolic signatures at the onset of systemic inflammation with lipopolysaccharide in the APPswe/PS1dE9 mouse model of Alzheimer’s disease
Open accessThe DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Abstract
Systemic inflammation enhances the risk and progression of Alzheimer's disease (AD). Lipopolysaccharide (LPS), a potent pro-inflammatory endotoxin produced by the gut, is found in excess levels in AD where it associates with neurological hallmarks of pathology. Sex differences in susceptibility to inflammation and AD progression have been reported, but how this impacts on LPS responses remains under investigated. We previously reported in an APP/PS1 model of AD that systemic LPS administration rapidly altered hippocampal metabolism in males. Here, we used untargeted metabolomics to comprehensively identify hippocampal metabolic processes occurring at onset of systemic inflammation with LPS (100 µg/kg, i.v.) in APP/PS1 mice, at an early pathological stage, and investigated the sexual dimorphism in this response. Four hours after LPS administration, pathways regulating energy metabolism, immune and oxidative stress responses were simultaneously recruited in the hippocampi of 4.5-month-old mice with a more protective response in females despite their pro-inflammatory and pro-oxidant metabolic signature in the absence of immune stimulation. LPS induced comparable behavioural sickness responses in male and female wild-type and APP/PS1 mice and comparable activation of both the serotonin and nicotinamide pathways of tryptophan metabolism in their hippocampi. Elevations in N-methyl-2-pyridone-5-carboxamide, a major toxic metabolite of nicotinamide, correlated with behavioural sickness regardless of sex, as well as with the LPS-induced hypothermia seen in males. Males also exhibited a pro-inflammatory-like downregulation of pyruvate metabolism, exacerbated in APP/PS1 males, and methionine metabolism whereas females showed a greater cytokine response and anti-inflammatory-like downregulation of hippocampal methylglyoxal and methionine metabolism. Metabolic changes were not associated with morphological markers of immune cell activation suggesting that they constitute an early event in the development of LPS-induced neuroinflammation and AD exacerbation. These data suggest that the female hippocampus is more tolerant to acute systemic inflammation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sex differences in immune responses
Klein, S. L., & Flanagan, K. L. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2016.90 · Cited by 6,370
The cholinergic hypothesis of Alzheimer’s disease: A review of progress
Francis, P. T., Palmer, A. M., Snape, M., & Wilcock, G. K. (1999) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.66.2.137 · Cited by 2,198 · cited 1×
“Loss of cholinergic function in AD is associated with memory decline (39).”
BackgroundMicroglia in Alzheimer’s disease
Hansen, D. V., Hanson, J. E., & Sheng, M. (2018) · Journal of Cell Biology · doi:10.1083/jcb.201709069 · Cited by 1,935 · cited 1×
“Microglia play a critical role in the clearance of Aβ and tau aggregates, and their dysfunction is associated with the genetic risk of developing AD (Hansen et al., 2018; Perea et al., 2018).”
Itaconate is an anti-inflammatory metabolite that activates Nrf2 via alkylation of KEAP1
Mills, E. L., Ryan, D. G., Prag, H. A., Dikovskaya, D., Menon, D., Zaslona, Z., Jedrychowski, M. P., Costa, A. S. H., Higgins, M., Hams, E., et al. (2018) · Nature · doi:10.1038/nature25986 · Cited by 1,885 · cited 2×
“anti-inflammatory TCA derivative found in immune cells (16), were also less abundant in the female”
BackgroundJankowsky, J. L., Fadale, D. J., Anderson, J., Xu, G. M., Gonzales, V., Jenkins, N. A., Copeland, N. G., Lee, M. K., Younkin, L. H., Wagner, S. L., et al. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh019 · Cited by 1,575 · cited 2×
“All PBS-treated groups, but female APP/ PS1, also showed a milder reduction in Y maze exploration 4 h after injection (p 0.05 in all cases, Fig.”
MethodInfluentialAlzheimer’s Disease Risk Genes and Mechanisms of Disease Pathogenesis
Karch, C. M., & Goate, A. M. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.05.006 · Cited by 1,357
O'Connor, J. C., Lawson, M. A., André, C., Moreau, M., Lestage, J., Castanon, N., Kelley, K. W., & Dantzer, R. (2009) · Molecular Psychiatry · doi:10.1038/sj.mp.4002148 · Cited by 1,278 · cited 3×
“This was associated with elevated levels of degradation products of both the serotonin and nicotinamide pathways of tryptophan metabolism, suggesting their co-activation, as seen previously (Guo et al., 2016; O'Connor et al., 2009; Parrott et al., 2016).”
Immune-responsive gene 1 protein links metabolism to immunity by catalyzing itaconic acid production
Michelucci, A., Cordes, T., Ghelfi, J., Pailot, A., Reiling, N., Goldmann, O., Binz, T., Wegner, A., Tallam, A., Rausell, A., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1218599110 · Cited by 1,191 · cited 2×
“Not known Not known Anti-inflammatory metabolite found in macrophages (16) and produced by microglia (125).”
BackgroundThe blood-brain barrier in systemic inflammation
Varatharaj, A., & Galea, I. (2017) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2016.03.010 · Cited by 1,172 · cited 3×
“This provides insights into how systemic LPS, whose brain penetration is poor at low dose and in the absence of blood brain barrier dysfunction (Banks and Robinson, 2010; Varatharaj and Galea, 2017), can trigger rapid inflammatory responses in the brain.”
Systemic inflammation and disease progression in Alzheimer disease
Holmes, C., Cunningham, C., Zotova, E., Woolford, J., Dean, C., Kerr, S., Culliford, D., & Perry, V. H. (2009) · Neurology · doi:10.1212/wnl.0b013e3181b6bb95 · Cited by 1,139 · cited 2×
“, 2019), and the presence of acute inflammatory events, such as respiratory infections or delirium have also been associated with exacerbations of clinical presentation and precipitous cognitive decline in AD patients (Holmer et al., 2018; Holmes et al., 2009; Ide et al., 2016).”
B Vitamins and the Brain: Mechanisms, Dose and Efficacy—A Review
Kennedy, D. (2016) · Nutrients · doi:10.3390/nu8020068 · Cited by 1,055 · cited 2×
“Substrate for the biosynthesis of coenzyme A which contributes to the structure and function of brain cells via its role in the synthesis and oxidation of fatty acids (71).”
BackgroundSex differences in Alzheimer disease — the gateway to precision medicine
for the Women’s Brain Project and the Alzheimer Precision Medicine Initiative, Ferretti, M. T., Iulita, M. F., Cavedo, E., Chiesa, P. A., Schumacher Dimech, A., Santuccione Chadha, A., Baracchi, F., Girouard, H., Misoch, S., et al. (2018) · Nature Reviews Neurology · doi:10.1038/s41582-018-0032-9 · Cited by 1,009
Systemic inflammation and microglial activation: systematic review of animal experiments
Hoogland, I. C. M., Houbolt, C., van Westerloo, D. J., van Gool, W. A., & van de Beek, D. (2015) · Journal of Neuroinflammation · doi:10.1186/s12974-015-0332-6 · Cited by 957 · cited 1×
“Indeed, morphological activation of microglia would generally occur 6 h after systemic administration of higher doses of LPS in the healthy brain (Hoogland et al., 2015), but within 4 h in the primed hippocampus (Murray et al.”
Sala Frigerio, C., Wolfs, L., Fattorelli, N., Thrupp, N., Voytyuk, I., Schmidt, I., Mancuso, R., Chen, W.-T., Woodbury, M. E., Srivastava, G., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.03.099 · Cited by 926 · cited 2×
“…of Aβ plaques, regardless of sex, but this response occurs earlier in females than in males (Frigerio et al., 2019), which can be related to the faster progression of cerebral amyloidosis consistently seen in females from this genotype (Frigerio et al., 2019; Li et al., 2016; Wang et al., 2003).”
BackgroundJenkins, T., Nguyen, J., Polglaze, K., & Bertrand, P. (2016) · Nutrients · doi:10.3390/nu8010056 · Cited by 904
Reduction of Abeta amyloid pathology in APPPS1 transgenic mice in the absence of gut microbiota
Harach, T., Marungruang, N., Duthilleul, N., Cheatham, V., Mc Coy, K. D., Frisoni, G., Neher, J. J., Fåk, F., Jucker, M., Lasser, T., et al. (2017) · Scientific Reports · doi:10.1038/srep41802 · Cited by 901
Peroxisomes and oxidative stress
Schrader, M., & Fahimi, H. D. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2006.09.006 · Cited by 838
Succinate: a metabolic signal in inflammation
Mills, E., & O’Neill, L. A. J. (2014) · Trends in Cell Biology · doi:10.1016/j.tcb.2013.11.008 · Cited by 741 · cited 1×
“Pro-inflammatory mediator in macrophages mediating LPSinduced IL-1β production (20, 94).”
BackgroundKreisel, T., Frank, M. G., Licht, T., Reshef, R., Ben-Menachem-Zidon, O., Baratta, M. V., Maier, S. F., & Yirmiya, R. (2014) · Molecular Psychiatry · doi:10.1038/mp.2013.155 · Cited by 663 · cited 1×
“This provided the percentage area occupied by glial cells, the number of Iba1- and GFAPpositive cells, used as a measure of microglial and astrocyte density, respectively, and the size of microglial soma, used as a morphometric marker of microglia activation and known to be sensitive to LPS (Kozlowski and Weimer, 2012…”
Sex-specific features of microglia from adult mice
Villa, A., Gelosa, P., Castiglioni, L., Cimino, M., Rizzi, N., Pepe, G., Lolli, F., Marcello, E., Sironi, L., Vegeto, E., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.05.048 · Cited by 651
Sochocka, M., Donskow-Łysoniewska, K., Diniz, B. S., Kurpas, D., Brzozowska, E., & Leszek, J. (2019) · Molecular Neurobiology · doi:10.1007/s12035-018-1188-4 · Cited by 584 · cited 1×
“This has led to the proposal that endogenous LPS accumulation could play a critical role in the pathophysiology of the common, sporadic form of AD (Pistollato et al., 2016; Sochocka et al., 2019; Zhan et al., 2018).”
BackgroundThe role of methionine on metabolism, oxidative stress, and diseases
Martínez, Y., Li, X., Liu, G., Bin, P., Yan, W., Más, D., Valdivié, M., Hu, C.-A. A., Ren, W., & Yin, Y. (2017) · Amino Acids · doi:10.1007/s00726-017-2494-2 · Cited by 583
Gram-negative bacterial molecules associate with Alzheimer disease pathology
Zhan, X., Stamova, B., Jin, L.-W., DeCarli, C., Phinney, B., & Sharp, F. R. (2016) · Neurology · doi:10.1212/wnl.0000000000003391 · Cited by 521 · cited 1×
“Circulating LPS levels are elevated in AD patients (Zhang et al., 2009) and the recent discoveries of LPS infiltration in the post-mortem AD brain where it associates with Aβ plaques, highlights the clinical relevance of this immune model (Zhan et al., 2018; Zhan et al., 2016; Zhao et al., 2017).”
BackgroundRole of gut microbiota and nutrients in amyloid formation and pathogenesis of Alzheimer disease
Pistollato, F., Sumalla Cano, S., Elio, I., Masias Vergara, M., Giampieri, F., & Battino, M. (2016) · Nutrition Reviews · doi:10.1093/nutrit/nuw023 · Cited by 496 · cited 1×
“This has led to the proposal that endogenous LPS accumulation could play a critical role in the pathophysiology of the common, sporadic form of AD (Pistollato et al., 2016; Sochocka et al., 2019; Zhan et al., 2018).”
Transcriptional and Translational Differences of Microglia from Male and Female Brains
Guneykaya, D., Ivanov, A., Hernandez, D. P., Haage, V., Wojtas, B., Meyer, N., Maricos, M., Jordan, P., Buonfiglioli, A., Gielniewski, B., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.08.001 · Cited by 477
Periodontitis and Cognitive Decline in Alzheimer’s Disease
Ide, M., Harris, M., Stevens, A., Sussams, R., Hopkins, V., Culliford, D., Fuller, J., Ibbett, P., Raybould, R., Thomas, R., et al. (2016) · PLOS ONE · doi:10.1371/journal.pone.0151081 · Cited by 461 · cited 1×
“, 2019), and the presence of acute inflammatory events, such as respiratory infections or delirium have also been associated with exacerbations of clinical presentation and precipitous cognitive decline in AD patients (Holmer et al., 2018; Holmes et al., 2009; Ide et al., 2016).”
Altered Gut Microbiota in a Mouse Model of Alzheimer’s Disease
Zhang, L., Wang, Y., Xiayu, X., Shi, C., Chen, W., Song, N., Fu, X., Zhou, R., Xu, Y.-F., Huang, L., et al. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170020 · Cited by 449 · cited 1×
“Differences in gut microbiota composition between genetic models of AD and their wild type control, consistent with endotoxemia and susceptibility to LPS, have been reported and found associated with the progression of cerebral amyloidosis (Brandscheid et al., 2017; Harach et al., 2017; Zhang et al., 2017).”
The sympathetic nervous response in inflammation
Pongratz, G., & Straub, R. H. (2014) · Arthritis Research & Therapy · doi:10.1186/s13075-014-0504-2 · Cited by 427
Capuron, L., Schroecksnadel, S., Féart, C., Aubert, A., Higueret, D., Barberger-Gateau, P., Layé, S., & Fuchs, D. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.12.006 · Cited by 368 · cited 2×
“people with chronic low grade inflammation (23) and prostaglandin-H2-ethanolamide (PGH2-EA) (Suppl.”
BackgroundMinimal penetration of lipopolysaccharide across the murine blood–brain barrier
Banks, W. A., & Robinson, S. M. (2010) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2009.09.001 · Cited by 356 · cited 2×
“This provides insights into how systemic LPS, whose brain penetration is poor at low dose and in the absence of blood brain barrier dysfunction (Banks and Robinson, 2010; Varatharaj and Galea, 2017), can trigger rapid inflammatory responses in the brain.”
Schwartz, M., & Baruch, K. (2014) · The EMBO Journal · doi:10.1002/embj.201386609 · Cited by 349
Zhang, R., Miller, R. G., Gascon, R., Champion, S., Katz, J., Lancero, M., Narvaez, A., Honrada, R., Ruvalcaba, D., & McGrath, M. S. (2009) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2008.09.017 · Cited by 319 · cited 1×
“Circulating LPS levels are elevated in AD patients (Zhang et al., 2009) and the recent discoveries of LPS infiltration in the post-mortem AD brain where it associates with Aβ plaques, highlights the clinical relevance of this immune model (Zhan et al.”
Altered Gut Microbiome Composition and Tryptic Activity of the 5xFAD Alzheimer’s Mouse Model
Brandscheid, C., Schuck, F., Reinhardt, S., Schäfer, K.-H., Pietrzik, C. U., Grimm, M., Hartmann, T., Schwiertz, A., & Endres, K. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-160926 · Cited by 318
Gender differences in the amount and deposition of amyloidβ in APPswe and PS1 double transgenic mice
Wang, J., Tanila, H., Puoliväli, J., Kadish, I., & Groen, T. V. (2003) · Neurobiology of Disease · doi:10.1016/j.nbd.2003.08.009 · Cited by 316
Snowden, S. G., Ebshiana, A. A., Hye, A., An, Y., Pletnikova, O., O’Brien, R., Troncoso, J., Legido-Quigley, C., & Thambisetty, M. (2017) · PLOS Medicine · doi:10.1371/journal.pmed.1002266 · Cited by 309 · cited 1×
“Reduced levels in the post-mortem AD brain (136, 144).”
BackgroundNAD metabolism: Implications in aging and longevity
Yaku, K., Okabe, K., & Nakagawa, T. (2018) · Ageing Research Reviews · doi:10.1016/j.arr.2018.05.006 · Cited by 269
Hart, A. D., Wyttenbach, A., Hugh Perry, V., & Teeling, J. L. (2012) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2011.11.006 · Cited by 230
Cunningham, C., & Hennessy, E. (2015) · Alzheimer's Research & Therapy · doi:10.1186/s13195-015-0117-2 · Cited by 211 · cited 2×
“In preclinical mouse models, lipopolysaccharide (LPS), mimicking gram-negative bacterial infection, and other acute systemic inflammatory stimuli have been found to exacerbate cognitive dysfunction, Aβ plaque load and tau phosphorylation (Barron et al., 2017; Cunningham and Hennessy, 2015; Nazem et al., 2015).”
What is the tryptophan kynurenine pathway and why is it important to neurotherapeutics?
Davis, I., & Liu, A. (2015) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2015.1049999 · Cited by 200 · cited 1×
“, 2017) and latter pro-inflammatory (Davis and Liu, 2015) and a major driver of LPS-induced sickness (O'Connor et al.”
Association between genetic traits for immune-mediated diseases and Alzheimer disease
Yokoyama, J. S., Wang, Y., Schork, A. J., Thompson, W. K., Karch, C. M., Cruchaga, C., McEvoy, L. K., Witoelar, A., Chen, C.-H., Holland, D., et al. (2016) · JAMA Neurology · doi:10.1001/jamaneurol.2016.0150 · Cited by 176
The Possibility of an Infectious Etiology of Alzheimer Disease
Ashraf, G. M., Tarasov, V. V., Makhmutovа, A., Chubarev, V. N., Avila-Rodriguez, M., Bachurin, S. O., & Aliev, G. (2019) · Molecular Neurobiology · doi:10.1007/s12035-018-1388-y · Cited by 175 · cited 2×
“Systemic inflammation is thought to be the mechanism whereby acute, accumulative or chronic infections can trigger AD pathogenesis (Ashraf et al., 2019; Giridharan et al., 2019).”
Genetics ignite focus on microglial inflammation in Alzheimer’s disease
Malik, M., Parikh, I., Vasquez, J. B., Smith, C., Tai, L., Bu, G., LaDu, M. J., Fardo, D. W., Rebeck, G. W., & Estus, S. (2015) · Molecular Neurodegeneration · doi:10.1186/s13024-015-0048-1 · Cited by 161 · cited 1×
“A number of genes conferring susceptibility to inflammatory conditions have indeed been found to be associated with a predisposition to AD (Karch and Goate, 2015; Malik et al., 2015; Yokoyama et al., 2016), whereas circulating levels of acute phase proteins or pro-inflammatory cytokines were found to be elevated in no…”
Sex differences in hippocampal function
Koss, W. A., & Frick, K. M. (2017) · Journal of Neuroscience Research · doi:10.1002/jnr.23864 · Cited by 156 · cited 1×
“Males are indeed generally found to outperform females for spatial working memory, and this has been related to differences in hippocampal morphology and function (Koss and Frick, 2017).”
Martin, E., Boucher, C., Fontaine, B., & Delarasse, C. (2017) · Aging Cell · doi:10.1111/acel.12522 · Cited by 156
Gaignard, P., Savouroux, S., Liere, P., Pianos, A., Thérond, P., Schumacher, M., Slama, A., & Guennoun, R. (2015) · Endocrinology · doi:10.1210/en.2014-1913 · Cited by 150 · cited 3×
“Sex differences in pyruvate metabolism have been associated with a higher mitochondrial respiration rate and reduced oxidative stress in females (Gaignard et al., 2015), as well as protection against oxidative damage induced by excitotoxic injury whereby the ratio of lipid peroxidation markers over…”
BackgroundZhao, L., Mao, Z., Woody, S. K., & Brinton, R. D. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.02.011 · Cited by 132
Taurine biosynthesis by neurons and astrocytes
Vitvitsky, V., Garg, S. K., & Banerjee, R. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.253344 · Cited by 131 · cited 1×
“5) in neurons, astrocytes and microglia (88, 89).”
BackgroundClark, R. A., Shoaib, M., Hewitt, K. N., Stanford, S. C., & Bate, S. T. (2012) · Journal of Psychopharmacology · doi:10.1177/0269881111420313 · Cited by 122 · cited 1×
“Data are presented as mean ± SEM (standard error of the mean) and were analysed using InVivoStat (Clark et al., 2012), unless otherwise stated.”
D-serine in glia and neurons derives from 3-phosphoglycerate dehydrogenase
Ehmsen, J. T., Ma, T. M., Sason, H., Rosenberg, D., Ogo, T., Furuya, S., Snyder, S. H., & Wolosker, H. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.4914-12.2013 · Cited by 118
Parrott, J. M., Redus, L., & O’Connor, J. C. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0590-y · Cited by 112 · cited 1×
“This was associated with elevated levels of degradation products of both the serotonin and nicotinamide pathways of tryptophan metabolism, suggesting their co-activation, as seen previously (Guo et al., 2016; O'Connor et al., 2009; Parrott et al., 2016).”
Pfalzer, A. C., Choi, S.-W., Tammen, S. A., Park, L. K., Bottiglieri, T., Parnell, L. D., & Lamon-Fava, S. (2014) · Physiological Genomics · doi:10.1152/physiolgenomics.00056.2014 · Cited by 90
Xu, J., Begley, P., Church, S. J., Patassini, S., McHarg, S., Kureishy, N., Hollywood, K. A., Waldvogel, H. J., Liu, H., Zhang, S., et al. (2016) · Scientific Reports · doi:10.1038/srep27524 · Cited by 85 · cited 1×
“Not known Elevated levels in the post-mortem AD brain (121).”
BackgroundSkelly, D. T., Hennessy, E., Dansereau, M.-A., & Cunningham, C. (2013) · PLoS ONE · doi:10.1371/annotation/90c76048-2edd-4315-8404-4d9d8cbd411e · Cited by 77 · cited 8×
“Consistent with our findings, LPSinduced hypothermia is generally found to be more severe in male than female mice (Cai et al., 2016; Card et al., 2006), suggesting that they experience more severe acute effects of LPS. Hypothermia is thought to be in part induced in response to changes in the brain as it did not appe…”
InfluentialLi, X., Feng, Y., Wu, W., Zhao, J., Fu, C., Li, Y., Ding, Y., Wu, B., Gong, Y., Yang, G., et al. (2016) · Laboratory Animals · doi:10.1177/0023677215615269 · Cited by 59 · cited 2×
“Preclinical data from genetically altered mouse models of AD indeed confirm that cerebral amyloidosis develops faster in females than in males (Li et al., 2016; Wang et al., 2003).”
Self-citationIsocitrate ameliorates anemia by suppressing the erythroid iron restriction response
Richardson, C. L., Delehanty, L. L., Bullock, G. C., Rival, C. M., Tung, K. S., Kimpel, D. L., Gardenghi, S., Rivella, S., & Goldfarb, A. N. (2013) · Journal of Clinical Investigation · doi:10.1172/jci68487 · Cited by 47
Cited by
The Impact of Systemic Inflammation on Alzheimer’s Disease Pathology
Xie, J., Van Hoecke, L., & Vandenbroucke, R. E. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2021.796867 · Cited by 324
Inflammatory pathways in Alzheimer’s disease mediated by gut microbiota
Qian, X.-H., Song, X.-X., Liu, X.-L., Chen, S.-D., & Tang, H.-D. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101317 · Cited by 153
Transmembrane protein 97 is a potential synaptic amyloid beta receptor in human Alzheimer’s disease
Colom-Cadena, M., Toombs, J., Simzer, E., Holt, K., McGeachan, R., Tulloch, J., Jackson, R. J., Catterson, J. H., Spires-Jones, M. P., Rose, J., et al. (2024) · Acta Neuropathologica · doi:10.1007/s00401-023-02679-6 · Cited by 44
Serum amyloid P secreted by bone marrow adipocytes drives skeletal amyloidosis
Kumar, S., Song, K., Wang, J., Baghel, M. S., Zeng, Y., Shen, K., Zheng, J., Crane, J., Demehri, S., Gao, P., et al. (2025) · Nature Aging · doi:10.1038/s43587-025-00924-z · Cited by 16
Metadata
- Authors
- Agostini, A., Yuchun, D., Li, B., Kendall, D. A., & Pardon, M.-C.
- Venue
- Brain, Behavior, and Immunity
- Publisher
- Elsevier BV
- Published
- 2020-01
- Volume
- 83
- Pages
- 87-111
- ISSN
- 0889-1591 (ISSN-L)
- OpenAlex
- W2976455298
- Cited by
- 41
- References
- 55
- FWCI
- 2.00
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.